Skip to content

OS Therapies OSTX Stock options excluded as their inclusion would be anti-dilutive (in shares)

Stock options excluded as their inclusion would be anti-dilutive (in shares) at other companies

Acco Brands logo
Acco BrandsACCO
8.4M-11.6%
SANUWAVE Health, Inc. logo
SANUWAVE Health, Inc.SNWV
1.5M-7.3%
Conduent Incorporated logo
Conduent IncorporatedCNDT
18.6M+41.3%
Diversified Energy
 logo
Diversified Energy DEC
2M+46.2%
Valvoline logo
ValvolineVVV
600K+500%
NFB
Northfield BancorpNFBK
140.2K-87.1%

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K
Free cash flow-$3.7M

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M

Returns & leverage

See full
Return on equity470%
Debt / equity-1.8×
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's stock options excluded as their inclusion would be anti-dilutive (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's stock options excluded as their inclusion would be anti-dilutive (in shares)?
OS Therapies (OSTX) reported stock options excluded as their inclusion would be anti-dilutive (in shares) of 12.6M in Q1 2026.
What does stock options excluded as their inclusion would be anti-dilutive (in shares) mean?
The number of potential common shares from stock options, warrants, or restricted stock units that are excluded from diluted earnings per share calculations because their inclusion would be antidilutive. This provides insight into the potential future dilution overhang that is currently excluded from standard EPS metrics.